Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

Condition:   Advanced Non-small Cell Lung Cancer Intervention:   Drug: almonertinib Sponsor:   Qianfoshan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials